An anti-inflammatory and anti-fibrotic proprietary Chinese medicine nasal spray designated as Allergic Rhinitis Nose Drops (ARND) with potential to prevent SARS-CoV-2 coronavirus infection by targeting RBD (Delta)- angiotensin converting enzyme 2 (ACE2) binding
Abstract Background Since the outbreak of COVID-19 has resulted in over 313,000,000 confirmed cases of infection and over 5,500,000 deaths, substantial research work has been conducted to discover agents/ vaccines against COVID-19. Undesired adverse effects were observed in clinical practice and com...
Saved in:
Main Authors: | Ka Man Yip (Author), Kwan Ming Lee (Author), Tzi Bun Ng (Author), Shujun Xu (Author), Ken Kin Lam Yung (Author), Shaogang Qu (Author), Allen Ka Loon Cheung (Author), Stephen Cho Wing Sze (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-fibrotic Potential of AT2 Receptor Agonists
by: Yan Wang, et al.
Published: (2017) -
Study of Potential Blocking Peptides Targeting the SARS-CoV-2 RBD/hACE2 Interaction
by: Sara M. Villada-Troncoso, et al.
Published: (2024) -
ACE2 : S1 RBD Interaction-Targeted Peptides and Small Molecules as Potential COVID-19 Therapeutics
by: Lennox Chitsike, et al.
Published: (2021) -
Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2
by: Arun Bahadur Gurung, et al.
Published: (2021) -
1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection
by: Rui Hong Chen, et al.
Published: (2021)